Braun, Gary B.
Friman, Tomas
Pang, Hong-Bo
Pallaoro, Alessia
de Mendoza, Tatiana Hurtado
Willmore, Anne-Mari A.
Kotamraju, Venkata Ramana
Mann, Aman P.
She, Zhi-Gang
Sugahara, Kazuki N.
Reich, Norbert O.
Teesalu, Tambet
Ruoslahti, Erkki
Article History
Received: 22 May 2013
Accepted: 14 April 2014
First Online: 8 June 2014
Competing interests
: The authors declare that K.N.S., V.R.K., T.T. and E.R. have ownership interest (including patents) in CendR Therapeutics. E.R. is also founder, chairman of the board of CendR Therapeutics. No potential conflicts of interest were disclosed by the other authors.